Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1992 Feb;140(2):521–528.

Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

H Noguchi 1, G M Kephart 1, T V Colby 1, G J Gleich 1
PMCID: PMC1886427  PMID: 1739138

Abstract

Eosinophilia has long been associated with endomyocardial fibrosis, but the involvement of the eosinophilia in fibrosis of other organs is unclear. To investigate this question, the authors tested whether tissue eosinophilia and eosinophil degranulation are present in syndromes associated with fibrosis. The authors used an indirect immunofluorescent technique to localize eosinophil granule major basic protein (MBP) in formalin-fixed, paraffin-embedded tissue specimens from 50 patients. Thirty-four specimens were obtained from patients with inflammatory fibrosis: 12 with idiopathic retroperitoneal fibrosis, seven with sclerosing mediastinitis, four with sclerosing cholangitis, and 11 with pulmonary fibrosis. The remaining 16 specimens were obtained from patients with noninflammatory fibrous proliferations: four with keloids, six with scars, three with Dupuytren's contracture and three with dense stromal fibrosis of the breast. Eosinophil infiltration and/or extracellular MBP deposition were observed in 28 of the 34 specimens (82%) from patients with inflammatory fibrosis, including 11 of the 12 cases of retroperitoneal fibrosis, five of the seven cases of sclerosing mediastinitis, all four cases of sclerosing cholangitis, and 8 of the 11 cases of pulmonary fibrosis. In contrast, eosinophil infiltration and MBP deposition were not observed in specimens from the 16 patients with noninflammatory fibrous proliferation (P less than 0.001). These results indicate that eosinophil infiltration and release of a granule protein, namely MBP, commonly occur in inflammatory fibrotic lesions.

Full text

PDF
521

Images in this article

522Figure 1
on p.522
523Figure 2
on p.523
524Figure 3
on p.524
525Figure 4
on p.525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beasley R., Roche W. R., Roberts J. A., Holgate S. T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989 Mar;139(3):806–817. doi: 10.1164/ajrccm/139.3.806. [DOI] [PubMed] [Google Scholar]
  2. Butterfield J. H., Kephart G. M., Banks P. M., Gleich G. J. Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease. Blood. 1986 Dec;68(6):1250–1256. [PubMed] [Google Scholar]
  3. Butterworth A. E., Wassom D. L., Gleich G. J., Loegering D. A., David J. R. Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol. 1979 Jan;122(1):221–229. [PubMed] [Google Scholar]
  4. Filley W. V., Ackerman S. J., Gleich G. J. An immunofluorescent method for specific staining of eosinophil granule major basic protein. J Immunol Methods. 1981;47(2):227–238. doi: 10.1016/0022-1759(81)90123-x. [DOI] [PubMed] [Google Scholar]
  5. Filley W. V., Holley K. E., Kephart G. M., Gleich G. J. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet. 1982 Jul 3;2(8288):11–16. doi: 10.1016/s0140-6736(82)91152-7. [DOI] [PubMed] [Google Scholar]
  6. Gleich G. J., Adolphson C. R. The eosinophilic leukocyte: structure and function. Adv Immunol. 1986;39:177–253. doi: 10.1016/s0065-2776(08)60351-x. [DOI] [PubMed] [Google Scholar]
  7. Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979 Dec;123(6):2925–2927. [PubMed] [Google Scholar]
  8. Gleich G. J., Loegering D. A., Mann K. G., Maldonado J. E. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest. 1976 Mar;57(3):633–640. doi: 10.1172/JCI108319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hertzman P. A., Blevins W. L., Mayer J., Greenfield B., Ting M., Gleich G. J. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med. 1990 Mar 29;322(13):869–873. doi: 10.1056/NEJM199003293221301. [DOI] [PubMed] [Google Scholar]
  10. Kierszenbaum F., Ackerman S. J., Gleich G. J. Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein. Am J Trop Med Hyg. 1981 Jul;30(4):775–779. doi: 10.4269/ajtmh.1981.30.775. [DOI] [PubMed] [Google Scholar]
  11. Krenik K. D., Kephart G. M., Offord K. P., Dunnette S. L., Gleich G. J. Comparison of antifading agents used in immunofluorescence. J Immunol Methods. 1989 Feb 8;117(1):91–97. doi: 10.1016/0022-1759(89)90122-1. [DOI] [PubMed] [Google Scholar]
  12. Ludwig J., Barham S. S., LaRusso N. F., Elveback L. R., Wiesner R. H., McCall J. T. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology. 1981 Nov-Dec;1(6):632–640. doi: 10.1002/hep.1840010612. [DOI] [PubMed] [Google Scholar]
  13. Maddox D. E., Kephart G. M., Coulam C. B., Butterfield J. H., Benirschke K., Gleich G. J. Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta. J Exp Med. 1984 Jul 1;160(1):29–41. doi: 10.1084/jem.160.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Martin R. W., Duffy J., Engel A. G., Lie J. T., Bowles C. A., Moyer T. P., Gleich G. J. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med. 1990 Jul 15;113(2):124–134. doi: 10.7326/0003-4819-113-2-124. [DOI] [PubMed] [Google Scholar]
  15. McCarter J. H., Vazquez J. J. The bronchial basement membrane in asthma. Arch Pathol. 1966 Oct;82(4):328–335. [PubMed] [Google Scholar]
  16. Noguchi H., Kephart G. M., Campbell R. J., Li J. T., Leiferman K. M., Trocme S. D., Gleich G. J. Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor. Ophthalmology. 1991 Jun;98(6):928–932. doi: 10.1016/s0161-6420(91)32200-0. [DOI] [PubMed] [Google Scholar]
  17. O'Donnell M. C., Ackerman S. J., Gleich G. J., Thomas L. L. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med. 1983 Jun 1;157(6):1981–1991. doi: 10.1084/jem.157.6.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Osborne B. M., Butler J. J., Bloustein P., Sumner G. Idiopathic retroperitoneal fibrosis (sclerosing retroperitonitis). Hum Pathol. 1987 Jul;18(7):735–739. doi: 10.1016/s0046-8177(87)80245-9. [DOI] [PubMed] [Google Scholar]
  19. Peters M. S., Rodriguez M., Gleich G. J. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest. 1986 Jun;54(6):656–662. [PubMed] [Google Scholar]
  20. Peters M. S., Schroeter A. L., Kephart G. M., Gleich G. J. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol. 1983 Jul;81(1):39–43. doi: 10.1111/1523-1747.ep12538380. [DOI] [PubMed] [Google Scholar]
  21. Pincus S. H., Ramesh K. S., Wyler D. J. Eosinophils stimulate fibroblast DNA synthesis. Blood. 1987 Aug;70(2):572–574. [PubMed] [Google Scholar]
  22. Rohrbach M. S., Wheatley C. L., Slifman N. R., Gleich G. J. Activation of platelets by eosinophil granule proteins. J Exp Med. 1990 Oct 1;172(4):1271–1274. doi: 10.1084/jem.172.4.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Samoszuk M., Sholly S., Epstein A. L. Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease. Lab Invest. 1987 Apr;56(4):394–400. [PubMed] [Google Scholar]
  24. Spry C. J., Davies J., Tai P. C., Olsen E. G., Oakley C. M., Goodwin J. F. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med. 1983 Winter;52(205):1–22. [PubMed] [Google Scholar]
  25. Tai P. C., Ackerman S. J., Spry C. J., Dunnette S., Olsen E. G., Gleich G. J. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet. 1987 Mar 21;1(8534):643–647. doi: 10.1016/s0140-6736(87)90412-0. [DOI] [PubMed] [Google Scholar]
  26. Ten R. M., Gleich G. J., Holley K. E., Perkins J. D., Torres V. E. Eosinophil granule major basic protein in acute renal allograft rejection. Transplantation. 1989 Jun;47(6):959–963. doi: 10.1097/00007890-198906000-00009. [DOI] [PubMed] [Google Scholar]
  27. Ten R. M., Kephart G. M., Posada M., Abaitua I., Soldevilla L., Kilbourne E. M., Dunnette S. L., Gleich G. J. Participation of eosinophils in the toxic oil syndrome. Clin Exp Immunol. 1990 Nov;82(2):313–317. doi: 10.1111/j.1365-2249.1990.tb05445.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wassom D. L., Gleich G. J. Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein. Am J Trop Med Hyg. 1979 Sep;28(5):860–863. [PubMed] [Google Scholar]
  29. Zheutlin L. M., Ackerman S. J., Gleich G. J., Thomas L. L. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol. 1984 Oct;133(4):2180–2185. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES